Taş F - Search Results

1

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.

Içli F, Celik I, Aykan F, Uner A, Demirkazik A, Ozet A, Ozgüroğlu M, Taş F, Akbulut H, Firat D. Içli F, et al. Among authors: tas f. Cancer. 1998 Dec 15;83(12):2475-80. Cancer. 1998. PMID: 9874451 Clinical Trial.

2

The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival.

Tas F, Aykan NF, Aydiner A, Uygun K, Basaran M, Camlica H, Topuz E. Tas F, et al. Am J Clin Oncol. 2000 Feb;23(1):53-7. doi: 10.1097/00000421-200002000-00015. Am J Clin Oncol. 2000. PMID: 10683078

3

Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day.

Aydiner A, Koyuncu H, Tas F, Topuz E, Disci R. Aydiner A, et al. Among authors: tas f. Int J Clin Pharmacol Res. 2000;20(1-2):21-30. Int J Clin Pharmacol Res. 2000. PMID: 11146899

4

The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.

Topuz E, Eralp Y, Saip P, Aydiner A, Taş F, Saliho Y, Salihoğlu Y, Berkman S, Bengisu E. Topuz E, et al. Among authors: tas f. Eur J Gynaecol Oncol. 2001;22(1):70-3. Eur J Gynaecol Oncol. 2001. PMID: 11321501

5

Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.

Tas F, Aykan F, Alici S, Kaytan E, Aydiner A, Topuz E. Tas F, et al. Am J Clin Oncol. 2001 Dec;24(6):547-50. doi: 10.1097/00000421-200112000-00003. Am J Clin Oncol. 2001. PMID: 11801751

6

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.

Basaran M, Bavbek ES, Sakar B, Eralp Y, Alici S, Tas F, Yaman F, Dogan O O, Camlica H, Onat H. Basaran M, et al. Among authors: tas f. Am J Clin Oncol. 2001 Dec;24(6):570-5. doi: 10.1097/00000421-200112000-00008. Am J Clin Oncol. 2001. PMID: 11801756 Clinical Trial.

7

Anemia in oncology practice: relation to diseases and their therapies.

Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E. Tas F, et al. Am J Clin Oncol. 2002 Aug;25(4):371-9. doi: 10.1097/00000421-200208000-00011. Am J Clin Oncol. 2002. PMID: 12151968

8

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study.

Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF. Topuz E, et al. Among authors: tas f. Am J Clin Oncol. 2002 Dec;25(6):619-24. doi: 10.1097/00000421-200212000-00019. Am J Clin Oncol. 2002. PMID: 12478012 Clinical Trial.

9

Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.

Tas F, Camlica H, Kurul S, Aydiner A, Topuz E. Tas F, et al. Clin Oncol (R Coll Radiol). 2003 May;15(3):132-5. doi: 10.1053/clon.2003.0205. Clin Oncol (R Coll Radiol). 2003. PMID: 12801051 Clinical Trial.

10

Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix.

Eralp Y, Saip P, Sakar B, Tas F, Aydiner A, Topuz E. Eralp Y, et al. Among authors: tas f. Eur J Gynaecol Oncol. 2003;24(3-4):323-6. Eur J Gynaecol Oncol. 2003. PMID: 12807249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters